Loading insider details...
Latest Form 4 (Feb 6, 2026): Sale of 1,655 TSHA shares, $7.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 6, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 1,655 | $7.5K |
| Jan 27, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 78,968 | $375.1K |
| Jan 14, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 359,000 | n/a |
| Aug 22, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 54,491 | $155.3K |
| Mar 13, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Tax Withholding | 29,843 | $50.4K |
| Jan 3, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 431,000 | n/a |
| Feb 6, 2024 | Taysha Gene Therapies, Inc. (TSHA) | Tax Withholding | 1,288 | $1.9K |
| Jan 4, 2024 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 590,413 | n/a |
| Dec 18, 2023 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 187,582 | n/a |
| Aug 25, 2023 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 33,000 | $76.9K |